The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects

Therapeutic Advances in Neurological Disorders
Per Soelberg Sorensen, Morten Blinkenberg

Abstract

B cells play a central role in the pathogenesis in multiple sclerosis (MS), being involved in the activation of proinflammatory T cells, secretion of proinflammatory cytokines, and production of autoantibodies directed against myelin. Hence, the usage of B-cell-depleting monoclonal antibodies as therapy for autoimmune diseases including MS lay near at hand. Rituximab was the first therapeutic B-cell-depleting chimeric monoclonal antibody to be used successfully in MS. Ocrelizumab, a second-generation humanized anti-CD20 antibody, was explored in a large phase II, randomized, placebo-controlled multicentre trial in patients with relapsing-remitting disease. Compared with placebo, two doses of ocrelizumab (600 and 2000 mg on days 1 and 15) showed a pronounced effect on disease activity seen in magnetic resonance imaging (MRI) as gadolinium-enhanced lesions (89% and 96% relative reduction, both p < 0.001) and also had a significant effect on relapses. In exploratory analyses, both doses of ocrelizumab had better effect on gadolinium-enhanced lesions than interferon beta-1a intramuscularly that was used as a reference arm. Adverse effects were mainly infusion-related reactions, in particular during the first infusion. Serious infec...Continue Reading

References

Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
May 16, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T W RuhstallerT Cerny
Dec 23, 2003·International Immunology·Junji UchidaThomas F Tedder
Mar 18, 2005·Annual Review of Immunology·Mireia Sospedra, Roland Martin
Oct 25, 2007·Brain : a Journal of Neurology·Manuel A Friese, Lars Fugger
Feb 15, 2008·The New England Journal of Medicine·Stephen L HauserUNKNOWN HERMES Trial Group
Apr 5, 2008·Current Opinion in Rheumatology·Thomas Dörner, Gerd R Burmester
May 4, 2010·Annals of Neurology·Amit Bar-OrCraig H Smith
Jun 19, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jakob Paues, Magnus Vrethem
Feb 15, 2011·Annual Review of Immunology·Shane Crotty
Mar 8, 2011·Annals of the Rheumatic Diseases·Maya H BuchUNKNOWN Rituximab Consensus Expert Committee
May 11, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Barbara Barun, Amit Bar-Or
Sep 1, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Ludwig KapposGilmore N O'Neill
Mar 14, 2012·Neurology·G DisantoS V Ramagopalan
Jul 27, 2012·Annals of the New York Academy of Sciences·Ira V Gupta, Roxanne C Jewell
May 18, 2013·Nature Reviews. Immunology·Stuart G TangyeElissa K Deenick
Jul 12, 2013·PloS One·Tamara Castillo-TrivinoEmmanuelle Waubant
Aug 24, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Deyaa El Deen MorsyJulie P Deans
Jan 21, 2014·Annual Review of Immunology·Lawrence Steinman
Mar 10, 2015·Neurology. Neuroimmunology and Neuroinflammation·Anders SvenningssonTommy Bergenheim

❮ Previous
Next ❯

Citations

Oct 12, 2016·Journal of Neuroimmunology·Daniel JonsOluf Andersen
Nov 3, 2016·Clinical and Experimental Immunology·A P JonesP H Hart
Nov 3, 2016·Clinical Pharmacology and Therapeutics·J L Orthmann-Murphy, P A Calabresi
Dec 3, 2016·Expert Opinion on Pharmacotherapy·Emanuele D'AmicoFrancesco Patti
Dec 22, 2016·The New England Journal of Medicine·Stephen L HauserUNKNOWN OPERA I and OPERA II Clinical Investigators
Mar 21, 2017·British Journal of Pharmacology·Ai-Lan NguyenJudith Field
Jun 18, 2017·Nature Reviews. Neurology·Paolo A MuraroRiccardo Saccardi
Jul 25, 2017·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Andrew D GaudetPhillip G Popovich
Dec 14, 2017·The Annals of Pharmacotherapy·Amanda M Stahnke, Kathryn M Holt
Nov 29, 2017·Journal of Neuroinflammation·David SchafflickGerd Meyer Zu Horste
Jul 17, 2018·Drug and Therapeutics Bulletin
May 14, 2019·Expert Review of Neurotherapeutics·Brandon WilbanksMoses Rodriguez
Sep 19, 2019·Current Medical Research and Opinion·Dirk DeleuAmir Boshra
Oct 31, 2017·Neurology. Neuroimmunology and Neuroinflammation·Divyanshu DubeyOlaf Stüve
Feb 29, 2020·Immunological Medicine·Wen Shi Lee, Olga Amengual
Feb 25, 2017·Current Infectious Disease Reports·S N Levin, T B Kaplan
Jun 6, 2017·Journal of Neuroscience Research·Heather YongJacqueline Quandt
Sep 25, 2017·Current Neurology and Neuroscience Reports·Elena Grebenciucova, Amy Pruitt
Sep 2, 2018·CNS Drugs·Yahiya Y Syed
Jan 5, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Moritz FörsterDavid Kremer
May 20, 2017·Drugs·James E Frampton
Apr 30, 2017·Therapeutic Advances in Neurological Disorders·Stefan BittnerSven G Meuth
Apr 9, 2018·Current Treatment Options in Neurology·John Robert Ciotti, Anne Haney Cross
Dec 6, 2018·Journal of Neurology·Thor Ameri ChalmerUNKNOWN Members of Danish Multiple Sclerosis Group
Nov 15, 2018·Archives of Pharmacal Research·Seon Min Yoo, Sung Hyun Chung
Mar 17, 2019·Biomedicines·Natalia V Voge, Enrique Alvarez
Jan 8, 2021·Neurology. Neuroimmunology and Neuroinflammation·José I Fernández-VelascoLuisa M Villar
Jan 26, 2021·Therapeutics and Clinical Risk Management·Ayse Bag-Ozbek, Joyce S Hui-Yuen
Feb 3, 2020·Multiple Sclerosis and Related Disorders·Staley A Brod
May 1, 2021·Journal of Personalized Medicine·María José Zarzuelo RomeroAlberto Jiménez Morales
Jun 3, 2021·Nature Reviews. Neurology·Maria T CencioniPaolo A Muraro
Jan 4, 2017·Molecular Pharmaceutics·Laura NorthrupCory Berkland
Sep 24, 2021·Current Pharmaceutical Design·Marcel GebhardtUwe K Zettl

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01412333
NCT01247324
NCT01194570

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.